KATARIA, B. C. Lorcaserin: a selective serotonin receptor (5-HT2C) agonist for the treatment of obesity. International Journal of Basic & Clinical Pharmacology, [S. l.], v. 1, n. 1, p. 45–47, 2017. Disponível em: https://www.ijbcp.com/index.php/ijbcp/article/view/1398. Acesso em: 24 oct. 2025.